Kongressthemen This action-packed two day agenda holds 13 Presentations from industry and academic leaders, 2 interactive panel/roundtable discussions, one interactive HCC workshop and over 4 hours of networking, you can join the only platform discussing issues present in the development of curative HBV therapeutics.
Kongressorganizer (PCO) Hanson Wade
Anmerkungen Speakers: Eduardo Bruno Martins | Vice President - Clinical Development | Abbvie, Yuchun Nie | Senior scientist | Aligos Therapeutics, Gaston Picchio | Chief Development Officer | Arbutus Biopharma and more.